Abstract:Background Nonadherence to antihypertensive medications is the leading cause of poor blood pressure control and thereby cardiovascular diseases and mortality worldwide. Methods and Results We investigated the global epidemiology, regional differences, and trend of antihypertensive medication nonadherence via a systematic review and meta‐analyses of data from 2010 to 2020. Multiple medical databases and clinicaltrials.gov were searched for articles. Observational studies reporting the proportion of patients with anti‐hypertensive medication nonadherence were included. The proportion of nonadherence, publication year, year of first recruitment, country, and health outcomes attributable to antihypertensive medication nonadherence were extracted. Two reviewers screened abstracts and full texts, classified countries according to levels of income and locations, and extracted data. The Joanna Briggs Institute prevalence critical appraisal tool was used to rate the included studies. Prevalence meta‐analyses were conducted using a fixed‐effects model, and trends in prevalence were analyzed using meta‐regression. The certainty of evidence concerning the effect of health consequences of nonadherence was rated according to Grading of Recommendations, Assessment, Development and Evaluations. A total of 161 studies were included. Subject to different detection methods, the global prevalence of anti‐hypertensive medication nonadherence was 27% to 40%. Nonadherence was more prevalent in low‐ to middle‐income countries than in high‐income countries, and in non‐Western countries than in Western countries. No significant trend in prevalence was detected between 2010 and 2020. Patients with antihypertensive medication nonadherence had suboptimal blood pressure control, complications from hypertension, all‐cause hospitalization, and all‐cause mortality. Conclusions While high prevalence of anti‐hypertensive medication nonadherence was detected worldwide, higher prevalence was detected in low‐ to middle‐income and non‐Western countries. Interventions are urgently required, especially in these regions. Current evidence is limited by high heterogeneity. Registration URL: www.crd.york.ac.uk/prospero/; Unique identifier: CRD42021259860. Nonstandard Abbreviations and Acronyms MMAS Morisky Medication Adherence Scale MPR medication possession ratio WHO World Health Organization Clinical Perspective What Is New? Anti‐hypertensive medication nonadherence was common globally (27%–40%), was more prevalent in low‐ to middle income and non‐Western countries, and did not improve between 2010 and 2020. What Are the Clinical Implications? Policymakers and clinicians should incorporate validated methods (eg, validated questionnaires, medication procession ratio, pill counting, electronic pills or pillbox, and biochemical detection by drug assays) into health care systems to routinely detect anti‐hypertensive medication nonadherence. Once detected, clinicians could conceptualize the reasons for nonadherence, using the World Health Organization model, and manage them accordingly. Medication adherence is defined as the "extent to which patients take their medication as prescribed." 1 , 2 Although hypertension is one of the most common chronic conditions and a leading cause of death globally, 3 medication nonadherence among patients with hypertension is highly prevalent. Up to 50% of patients stop taking their prescribed antihypertensive medications within 1 year of initiation. 4 The high prevalence of antihypertensive medication nonadherence has contributed to poor blood pressure (BP) control worldwide. Accordingly, optimal control of BP is attained in less than one‐third and one‐tenth of patients with hypertension in high‐income and low‐ to middle‐income countries, respectively. 1 , 3 This poor control has consequently led to a high global burden of cardiovascular diseases, chronic kidney disease, dementia, and mortality. The World Health Organization (WHO) has provided a conceptual framework to explain the multifactorial reasons underlying antihypertensive medicati -Abstract Truncated-

Factors associated with poor adherence to medication in patients with diabetes and hypertension in Peru: findings from a pooled analysis of six years of population-based surveys

Socioeconomic Inequalities in Non-Adherence to Antihypertensive Medication in Peru

Patient, family, and community factors associated with medication adherence among people with hypertension or diabetes: A cross-sectional analysis

Cross-sectional analysis of factors associated with medication adherence in western Kenya

Prevalence, Trends, and Associated Factors of Isolated Systolic, Diastolic, and Systolic-Diastolic Hypertension in Peru: A Nine-Year Analysis of the Demographic and Family Health Survey

Association Between Health Literacy and Medication Adherence Among Hispanics with Hypertension

GLOBAL BURDEN, REGIONAL DIFFERENCES, TRENDS, AND HEALTH CONSEQUENCES OF MEDICATION NON-ADHERENCE IN PATIENTS WITH HYPERTENSION DURING 2010-2020: A SYSTEMATIC REVIEW AND META-ANALYS

Hypertension prevalence by degrees of urbanization and altitude in Peru: pooled analysis of 186 906 participants

Risk-based antihypertensive treatment allocation in Peru: comparison of local and international guidelines analysing national health surveys between 2015-2020

Impact of Socio–Economic, Health and Patient Related Factors on Medication Adherence in Patients with Hypertension and Type II Diabetes

Factors Associated with the Frequency of Medical Consultations in 1,355,354 Patients with Various Types of Diabetes Mellitus

Prevalence, reasons and factors associated with intentional nonadherence to prescribed medications: a population-based study

Medication adherence and associated factors among chronic heart failure patients on follow-up in north Shewa public hospitals, Oromia region, Ethiopia

Factors Contributing to Lack of Adherence to Antihypertensive Medications Among Patients at Nishtar Hospital in Multan, Pakistan

Overall medication adherence as an indicator for health outcomes among elderly patients with hypertension and diabetes

Factors influencing long-term medication non-adherence among diabetes and hypertensive patients in Ghana: A qualitative investigation

Effect of medication adherence on blood pressure control and risk factors for antihypertensive medication adherence.

Assessment of Medication Adherence Among Patients With Hypertension and Diabetes Mellitus in a Tertiary Healthcare Center: A Descriptive Study

Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta‐Analysis Involving 27 Million Patients

Patient Perspectives on Factors Influencing Medication Adherence Among People with Coronary Heart Disease (CHD) and CHD Risk Factors

O44 LOW ADHERENCE TO HYPERTENSION MANAGEMENT IN THE COLOMBIAN COMMUNITY IMPLEMENTATION RE-HOPE STUDY